27
Mar
Harnessing Genetically Engineered Bacteria for Human Insulin Production: A Molecular Transformation in Diabetes Therapy Insulin represents a fundamental hormone in metabolic regulation and constitutes the cornerstone of therapy for patients with Diabetes mellitus. This chronic metabolic disorder currently affects 537 million adults worldwide according to the 2023 International Diabetes Federation report, with projections reaching 643 million by 2030 and 783 million by 2045. The disease accoun
